User profiles for Seng H. Cheng

Seng H. Cheng

Alexion, AstraZeneca Rare Disease
Verified email at alexion.com
Cited by 32592

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis

SH Cheng, RJ Gregory, J Marshall, S Paul, DW Souza… - Cell, 1990 - cell.com
The gene associated with cystic fibrosis (CF) encodes a membrane-associated, N-linked
glycoprotein called CFTR. Mutations wem introduced into CFTR at residues known to be …

[PDF][PDF] Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis

…, KA Pytel, JW Artates, A Weiss, SH Cheng… - Neuron, 2012 - cell.com
The primary cause of Huntington's disease (HD) is expression of huntingtin with a
polyglutamine expansion. Despite an absence of consensus on the mechanism(s) of toxicity, …

Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel

SH Cheng, DP Rich, J Marshall, RJ Gregory, MJ Welsh… - Cell, 1991 - cell.com
CFTR, the protein associated with cystic fibrosis, is phosphorylated on serine residues in
response to CAMP agonists. Serines 660, 737, 795, and 613 were identified as in vivo targets …

Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells

DP Rich, MP Anderson, RJ Gregory, SH Cheng, S Paul… - Nature, 1990 - nature.com
The cystic fibrosis transmembrane conductance regulator (CFTR) was expressed in cultured
cystic fibrosis airway epithelial cells and Cl − channel activation assessed in single cells …

Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy

…, AR Krainer, CF Bennett, SH Cheng - Science translational …, 2011 - science.org
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused
by mutations in the SMN1 gene that result in a deficiency of SMN protein. One approach to …

[HTML][HTML] Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

…, R Calcedo, P Carvelli, M Chan, SH Cheng… - The Lancet …, 2015 - thelancet.com
Background Lung delivery of plasmid DNA encoding the CFTR gene complexed with a
cationic liposome is a potential treatment option for patients with cystic fibrosis. We aimed to …

Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung

…, RK Scheule, DJ Harris, AE Smith, SH Cheng - Human gene …, 1996 - liebertpub.com
Cationic lipid-mediated gene transfer of cystic fibrosis transmembrane conductance regulator
(CFTR) cDNA represents a promising approach for treatment of cystic fibrosis (CF). Here, …

Targeting nuclear RNA for in vivo correction of myotonic dystrophy

…, SK Pandey, AR MacLeod, M Nakamori, SH Cheng… - Nature, 2012 - nature.com
Antisense oligonucleotides (ASOs) hold promise for gene-specific knockdown in diseases
that involve RNA or protein gain-of-function effects. In the hereditary degenerative disease …

Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors

…, KA Vincent, GY Akita, T Kuriyama, SH Cheng… - Circulation …, 2003 - Am Heart Assoc
Hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of vascular endothelial
growth factor (VEGF) and other hypoxia-responsive genes. Transgenic expression of a …

Expression and characterization of the cystic fibrosis transmembrane conductance regulator

RJ Gregory, SH Cheng, DP Rich, J Marshall, S Paul… - Nature, 1990 - nature.com
CYSTIC fibrosis (CF) is a common lethal genetic disease that manifests itself in airway and
other epithelial cells as defective chloride ion absorption and secretion 1,2 , resulting at least …